Abstract:Background: Although lymphedema is a progressive and lifelong condition, substantial advances in therapeutic intervention are limited. The development of a novel therapy for lymphedema is urgent for those patients suffering from it. The aim of this study was to investigate the usefulness of a new cell transplantation therapy in the rat tail model of secondary lymphedema. Materials and methods: We prepared two cell sources, human dermal microvascular endothelial cells (HDMECs) and lymphatic endothelial cells (LECs), which were collected from the resected normal dermis of patients with breast cancer. After the animal model of secondary lymphedema of the nude rats' tails was established, phosphate-buffered saline, purified LECs, or unpurified HDMECs were injected in the rats' tails five times for more than 14 d. The evaluations were performed by measuring the circumference, fluorescence lymphography, and histologic analysis of the rats' tails between each group. Results: The isolated cells by the simple immunomagnetic sorting from HDMECs were positive for a pan-endothelial marker (CD31) and lymphatic-specific markers (podoplanin, lymphatic vessel endothelial hyaluronan receptor-1 [LYVE-1], and prospero homebox 1 [Prox-1]), and were considered to be LECs. In the cell transplantation group, which was injected with human LECs, the circumference, lymphatic flow, and thickness of the skin of the rat tail became thinner than the groups injected with unpurified HDMECs or phosphate-buffered saline. Immunohistochemistry of the rat tails showed that the number of own lymphatic vessels was increased in the purified LEC transplantation group compared with the other groups. Furthermore, in the LEC transplantation group, some vessels were immunopositive for human-podoplanin or -LYVE-1 and the areas adjacent to the vessels were rat-podoplanin or -LYVE-1 immunopositive. Conclusions: Our findings indicate that cell transplantation therapy using human LECs improved the secondary lymphedema in the nude rat tail. This therapeutic strategy may merit clinical investigation in patients with lymphedema.

A reproducible in-vivo model of lymphatic malformation in rats

A new vascularized cervical lymph node transplantation model: an anatomic study in rats

NEW MODEL OF REVERSIBLE OBSTRUCTIVE-JAUNDICE IN RATS

Photothrombosis Combined with Thrombin Injection Establishes a Rat Model of Cerebral Venous Sinus Thrombosis.

A Novel Ex Vivo Tumor Spheroid-Tissue Model for Investigating Microvascular Remodeling and Lymphatic Blood Vessel Plasticity

Liver Tumor Model with Implanted Rhabdomyosarcoma in Rats: MR Imaging, Microangiography, and Histopathologic Analysis.

Modeling Structural Elements and Functional Responses to Lymphatic-Delivered Cues in a Murine Lymph Node on a Chip

Validation of laser scanning confocal microscopy as a diagnostic method for lymphedema using a rat model

A Pre-clinical Animal Model of Secondary Head and Neck Lymphedema

Mouse Corneal Lymphangiogenesis Model

A Preliminary Study of Murine Hemangioma Model by Delivery of Recombinant Adeno-Associated Virus Mediated Human Vascular Endothelial Growth Factor-121 Gene

A Novel Transgenic Mice Model for Venous Malformation

Lymphatic regeneration following microvascular limb replantation: a qualitative and quantitative animal study

A vascularized bone marrow transplantation model in rat

Lymphaticovenous anastomosis in rabbits: A novel live experimental animal model for supermicrosurgical training

A Preliminary Study on the Establishment of a Cyst and Cystic Neoplasm Tissue-Mimicking Model.

Visualization of fluid drainage pathways in lymphatic vessels and lymph nodes using a mouse model to test a lymphatic drug delivery system

Establishment and Evaluation of a Sprague-Dawley Rat Model of Intramedullary Spinal Cord Glioma

A Novel Immunocompetent Murine Tumor Model for the Evaluation of RCAd-enhanced RDAd Transduction Efficacy

A Novel Model for Cutaneous Wound Healing and Scarring in the Rat

Cell transplantation therapy for a rat model of secondary lymphedema